The musculo-skeletal system medicine sales in Italy are forecasted to grow from €599.7 million in 2024 to €621.3 million in 2028. This represents a steady, albeit modest, increase over the outlined period. The expected year-on-year growth rates exhibit a slight decline: 1.21% from 2024 to 2025, 0.97% from 2025 to 2026, 0.75% from 2026 to 2027, and 0.62% from 2027 to 2028. Over the five-year forecast period, the compound annual growth rate (CAGR) is approximately 0.88%, reflecting a consistent increase in sales.

Future trends to watch for include:

Advancements in musculoskeletal treatments and technologies that could raise demand.
Healthcare policy changes in Italy that might impact market dynamics.
Demographic shifts, such as an aging population, possibly driving higher consumption.
Economic factors influencing patient and provider spending behavior.